Indium-111 octreotide uptake in the surgical scar

Area of Science:

• Nuclear medicine
• Oncology
• Immunology

Background:

• Indium-111 octreotide is used to image somatostatin receptor-positive tumors.
• Uptake has been noted in various conditions involving activated leukocytes, such as granulomas and autoimmune diseases.
• Carcinoid tumors express somatostatin receptors, making octreotide imaging a relevant diagnostic tool.

Observation:

• The study observed Indium-111 octreotide uptake in surgical abdominal scar tissue.
• This uptake was noted 1.5 and 6 months post-surgery in a patient treated for recurrent rectosigmoid carcinoid tumor.
• The patient's history included treatment for carcinoid tumor, a condition often managed with somatostatin analogs.

Findings:

• Indium-111 octreotide uptake in surgical scars is a previously unreported phenomenon.
• The uptake in scar tissue is hypothesized to be due to somatostatin receptor binding.
• Activated lymphocytes and fibroblasts within the scar tissue are suggested as the source of these receptors.

Implications:

• This finding expands the understanding of Indium-111 octreotide uptake beyond neoplastic and inflammatory conditions.
• It suggests that post-surgical scar tissue can exhibit somatostatin receptor expression.
• Further research may clarify the clinical significance and diagnostic utility of octreotide uptake in surgical scars.